Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Brinkmann

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|September 18, 2024
Development and Validation of a High-Performance Liquid Chromatography-Ultraviolet Spectrometry Method for Ampicillin and Its Application in Routine Therapeutic Drug Monitoring of Intensive Care PatientsBenedict Morath, Linda Schultes, Otto Roman Frey, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2023
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement TherapyLea Marie Schatz, Alexander Brinkmann, Anka Röhr, et al.
The International Journal of Artificial Organs|December 15, 2018
In vitro removal of anti-infective agents by a novel cytokine adsorbent systemChristina König, Anka C Röhr, Otto R Frey, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill PatientsUte Chiriac, Daniel Richter, Otto R Frey, et al.
BMC Anesthesiology|July 13, 2017
End-of-life perceptions among physicians in intensive care units managed by anesthesiologists in Germany: a survey about structure, current implementation and deficitsManfred Weiss, Andrej Michalsen, Anke Toenjes, et al.
Therapeutic Drug Monitoring|December 3, 2021
Antibiotic Stewardship and Therapeutic Drug Monitoring of β-Lactam Antibiotics: Is There a Link? An Opinion PaperDaniel C Richter, Alexandra Heininger, Ute Chiriac, et al.
Trials|June 8, 2019
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trialStefan Hagel, Sandra Fiedler, Andreas Hohn, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial DosingUte Chiriac, Daniel C Richter, Otto R Frey, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2026
Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysisUte Chiriac, Max Münchow, Anka C Röhr, et al.
Infection|September 2, 2019
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experienceDaniel C Richter, Otto Frey, Anka Röhr, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|September 18, 2024
Development and Validation of a High-Performance Liquid Chromatography-Ultraviolet Spectrometry Method for Ampicillin and Its Application in Routine Therapeutic Drug Monitoring of Intensive Care PatientsBenedict Morath, Linda Schultes, Otto Roman Frey, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2023
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement TherapyLea Marie Schatz, Alexander Brinkmann, Anka Röhr, et al.
The International Journal of Artificial Organs|December 15, 2018
In vitro removal of anti-infective agents by a novel cytokine adsorbent systemChristina König, Anka C Röhr, Otto R Frey, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill PatientsUte Chiriac, Daniel Richter, Otto R Frey, et al.
BMC Anesthesiology|July 13, 2017
End-of-life perceptions among physicians in intensive care units managed by anesthesiologists in Germany: a survey about structure, current implementation and deficitsManfred Weiss, Andrej Michalsen, Anke Toenjes, et al.
Therapeutic Drug Monitoring|December 3, 2021
Antibiotic Stewardship and Therapeutic Drug Monitoring of β-Lactam Antibiotics: Is There a Link? An Opinion PaperDaniel C Richter, Alexandra Heininger, Ute Chiriac, et al.
Trials|June 8, 2019
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trialStefan Hagel, Sandra Fiedler, Andreas Hohn, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial DosingUte Chiriac, Daniel C Richter, Otto R Frey, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2026
Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysisUte Chiriac, Max Münchow, Anka C Röhr, et al.
Infection|September 2, 2019
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experienceDaniel C Richter, Otto Frey, Anka Röhr, et al.
Pageof 5